The Global Uramustine (CAS 66-75-1) Market is expected to reach US$ 35.8 Million by 2028, growing at a Compound Annual Growth Rate (CAGR) of 3.9% during the forecast period (2023–2028). This growth is primarily driven by the persistent demand for effective chemotherapeutic agents, ongoing clinical research in hematologic malignancies, and the critical role of Uramustine as a nitrogen mustard alkylating agent in combination therapies.

As the oncology therapeutics landscape continues to evolve with a focus on targeted treatments, the production and supply of key active pharmaceutical ingredients like Uramustine remain crucial. In this analysis, we profile the Top 10 Companies in the Uramustine Industry—a mix of established pharmaceutical giants, specialized chemical suppliers, and research chemical providers supporting global cancer treatment and research initiatives.

Download FREE Sample Report:
2023-2028 Global and Regional Uramustine (CAS 66-75-1) Industry Status and Prospects Professional Market – View in Detailed Research Report

---

🔟 1. Merck KGaA

Headquarters: Darmstadt, Germany
Key Offering: Uramustine API, Research-grade Uramustine

Merck KGaA, operating through its MilliporeSigma division, is a leading global supplier of high-purity Uramustine for pharmaceutical research and development. The company provides this critical alkylating agent to research institutions, pharmaceutical companies, and academic laboratories worldwide, supporting ongoing oncology drug development programs.

Research and Development Initiatives:

• High-purity active pharmaceutical ingredient (API) manufacturing

• Support for combination therapy research in hematologic cancers

• Strict quality control adhering to pharmacopeia standards

---

9️⃣ 2. DC Chemicals

Headquarters: Shanghai, China
Key Offering: Uramustine (CAS 66-75-1) in various purities

DC Chemicals has established itself as a significant supplier of pharmaceutical intermediates and fine chemicals, including Uramustine. The company serves both domestic Chinese pharmaceutical manufacturers and international clients, with capabilities in scale-up production to meet commercial demands.

Research and Development Initiatives:

• Process optimization for cost-effective manufacturing

• Expansion of cGMP compliant production facilities

---

8️⃣ 3. Synchem Inc.

Headquarters: Nanjing, China
Key Offering: Custom synthesis of Uramustine and derivatives

Synchem specializes in the custom synthesis of complex organic molecules, including Uramustine for pharmaceutical applications. The company focuses on developing efficient synthetic routes and providing kilogram-scale quantities to support drug development programs.

Research and Development Initiatives:

• Development of novel synthetic methodologies

• Scale-up services from laboratory to pilot plant scale

---

7️⃣ 4. AA Blocks

Headquarters: Utrecht, Netherlands
Key Offering: Building blocks and research chemicals including Uramustine

AA Blocks provides chemical building blocks for drug discovery and development, offering Uramustine to research institutions and pharmaceutical companies. The company emphasizes quality and rapid delivery to support time-sensitive research projects in oncology.

Research and Development Initiatives:

• Quality assurance through rigorous analytical testing

• Global logistics network for efficient research material distribution

Download FREE Sample Report:
2023-2028 Global and Regional Uramustine (CAS 66-75-1) Industry Status and Prospects Professional Market – View in Detailed Research Report

---

6️⃣ 5. 3B Scientific Corporation

Headquarters: Hong Kong, China
Key Offering: Uramustine for research and development purposes

3B Scientific Corporation supplies biochemicals and pharmaceutical intermediates to the global research community. The company provides Uramustine to academic institutions and research organizations studying cancer mechanisms and developing new therapeutic approaches.

Research and Development Initiatives:

• Support for academic research in oncology and pharmacology

• Maintenance of comprehensive chemical inventory for research continuity

---

5️⃣ 6. Adooq Bioscience

Headquarters: Irvine, California, USA
Key Offering: High-purity Uramustine for biological research

Adooq Bioscience specializes in providing bioactive small molecules for life science research, including Uramustine for cancer biology studies. The company focuses on ensuring compound purity and stability to support reproducible research outcomes in cellular and animal models.

Research and Development Initiatives:

• Rigorous quality control for biological activity confirmation

• Development of formulation strategies for research applications

---

4️⃣ 7. Conscientia Industrial Co., Ltd.

Headquarters: Dalian, China
Key Offering: Pharmaceutical intermediates including Uramustine

Conscientia Industrial is a chemical supplier with expertise in manufacturing pharmaceutical intermediates and fine chemicals. The company supplies Uramustine to pharmaceutical companies and contract manufacturing organizations engaged in oncology drug production.

Research and Development Initiatives:

• Process development for intermediate manufacturing

• Collaboration with pharmaceutical partners on custom synthesis projects

---

3️⃣ 8. Tokyo Chemical Industry Co., Ltd. (TCI)

Headquarters: Tokyo, Japan
Key Offering: Laboratory chemicals including Uramustine for research

TCI is a leading global supplier of laboratory chemicals and pharmaceutical intermediates, providing high-purity Uramustine to research institutions worldwide. The company maintains stringent quality standards and offers comprehensive technical documentation for research applications.

Research and Development Initiatives:

• Expansion of oncology research compound portfolio

• Development of analytical methods for impurity profiling

---

2️⃣ 9. BOC Sciences

Headquarters: Shirley, New York, USA
Key Offering: Uramustine reference standards and APIs

BOC Sciences provides chemical products and services to the pharmaceutical and biotechnology industries, including Uramustine in various purities. The company specializes in supplying reference standards and analytical services to support drug development and regulatory compliance.

Research and Development Initiatives:

• Development of certified reference materials

• Analytical method development and validation services

---

1️⃣ 10. Santa Cruz Biotechnology, Inc.

Headquarters: Dallas, Texas, USA
Key Offering: Biochemicals and research reagents including Uramustine

Santa Cruz Biotechnology supplies research antibodies, biochemicals, and labware to the global scientific community. The company offers Uramustine for research purposes, supporting studies in cancer biology, drug mechanisms, and therapeutic development.

Research and Development Initiatives:

• Integration with complementary research reagents

• Support for multidisciplinary cancer research programs

Get Full Report Here:
2023-2028 Global and Regional Uramustine (CAS 66-75-1) Industry Status and Prospects Professional Market – View in Detailed Research Report

---

🔬 Outlook: The Future of Uramustine in Evolving Cancer Therapeutics

The Uramustine market is experiencing steady growth despite the emergence of newer targeted therapies. While modern oncology increasingly focuses on biologics and immunotherapies, traditional alkylating agents like Uramustine continue to play essential roles in combination regimens and specific clinical scenarios.

📈 Key Trends Shaping the Market:

• Sustained demand in emerging markets with limited access to expensive biologics

• Research into optimized combination therapies incorporating alkylating agents

• Increasing quality standards and regulatory requirements for API manufacturing

• Growing pharmaceutical research activities in academic and institutional settings

Get Full Report Here:
2023-2028 Global and Regional Uramustine (CAS 66-75-1) Industry Status and Prospects Professional Market – View in Detailed Research Report

The companies profiled above are crucial not only for supplying this important chemotherapeutic agent but also for supporting the ongoing research that may lead to improved cancer treatment protocols and patient outcomes worldwide.